Alzheimer’s patients divided on costly new drug: a ‘magic pill’ or ‘risk I’m willing to take’
Medicare has proposed limiting coverage of Aduhelm. Key groups representing patients and families are pressing to make it more widely available. Among people facing the disease, the outlook is more nuanced.
Chicago Sun-Times ·